This page is part of the Evidence Based Medicine on FHIR Implementation Guide (v1.0.0-ballot: STU1 Ballot 1) based on FHIR (HL7® FHIR® Standard) v5.0.0. . For a full list of available versions, see the Directory of published versions
Resource Group "179785" Version "4" Updated "2023-12-04 20:30:06+0000"
Profile: ComparatorDefinition
Artifact related artifact:
Artifact Title: ComparatorDefinition: Usual-care pharmacologic thromboprophylaxis
Artifact URL: https://fevir.net/resources/Group/179785
Artifact Publisher: Computable Publishing LLC
Artifact Copyright: https://creativecommons.org/licenses/by-nc-sa/4.0/
Artifact Contact: support@computablepublishing.com
Artifact Author: Brian S. Alper:
CombinationMethod: any-of
modifierExtension[http://hl7.org/fhir/StructureDefinition/artifact-status]
identifier: FEvIR Object Identifier: 179785
type: animal
membership: definitional
name: ComparatorDefinition_Usual_care_pharmacologic_thromboprophylaxis
description: Description: usual-care pharmacologic thromboprophylaxis Note: Thromboprophylaxis was provided at a dose and duration determined by the treating clinician according to local practice. Note: Usual-care pharmacological thromboprophylaxis included both intermediate-intensity (in 27%) and prophylactic-intensity dosing (in 72%). Subgroup analyses may be informative to determine if there is a difference related to the intensity used in the control arm of the trial.
characteristic
CharacteristicDescription: ATTACC comparator arm
CharacteristicTiming
url
contextCode
value: Start of trial ()
url
offset
value: 0-14
url
text
value: Up to 14 days or until hospital discharge, whichever comes first. After this period, decisions regarding thromboprophylaxis are at discretion of treating clinician.
code: Defined by CodeableConcept ()
value: Standard venous thromboprophylaxis according to local guidelines or usual practice. Dose of chosen agent should not be more than half of the approved therapeutic dose for the treatment of venous thromboembolism. ()
exclude: false
characteristic
CharacteristicDescription: ACTIV-4a comparator arm
CharacteristicTiming
url
contextCode
value: Start of trial ()
url
offset
value: 0-14
url
text
value: Up to 14 days or until hospital discharge, whichever comes first. After this period, decisions regarding thromboprophylaxis are at discretion of treating clinician.
code: Defined by CodeableConcept ()
value: Any one of enoxaparin, dalteparin, tinzaparin, fondaparinux, or heparin according to local preference. Dose of agent specified to be consistent with guidelines for low dose thromboprophylaxis. ()
exclude: false
characteristic
CharacteristicDescription: REMAP-CAP comparator arm
CharacteristicTiming
url
contextCode
value: Start of trial ()
url
offset
value: 0-14
url
text
value: Up to 14 days or until hospital discharge, whichever comes first. After this period, decisions regarding thromboprophylaxis are at discretion of treating clinician.
code: Defined by CodeableConcept ()
value: Standard venous thromboprophylaxis according to local guidelines or usual practice. Dose of chosen agent should not be sufficient to result in therapeutic anticoagulation. ()
exclude: false